Pfizer (NY: PFE )
36.52 USD -0.18 (-0.49%) Official Closing Price Updated: 5:37 PM EST, Nov 23, 2020 Add to My Watchlist
All news about Pfizer
The stock market climbed unevenly Monday, with small caps and certain sectors doing much better than the Nasdaq composite and S&P 500.
Rising COVID-19 cases raise the specter of another global glut of crude oil. But spreads between near- and far-dated oil futures are telling a different story.
Today 16:40 EST
China is enforcing new discipline not only on the private sector giants but also on its state-owned companies.
The construction business has boomed during the coronavirus pandemic. That’s according to Seth Helfman, the president at ...
AstraZeneca plc (NASDAQ: AZN) announced Monday interim Phase 3 data for its coronavirus vaccine candidate AZD1222 from studies ...
Are Markets Tiring of Monday Vaccine Announcements?
Today 13:40 EST
Steve Sosnick, Interactive Brokers’ chief strategist, discusses the additional vaccine news and the market activity for the day.
AstraZeneca’s COVID-19 vaccine data fails to impress Wall Street analysts with its effectiveness in clinical trials
Today 13:38 EST
AstraZeneca’s experimental COVID-19 vaccine is the third vaccine to demonstrate it can prevent coronavirus infections in a late-stage clinical trial, though the viral vector-based vaccine is much less...
Last Week's IPO Recap
Today 12:45 EST
Last week brought us six new IPOs. Among these, breast cancer biotech company Olema Pharmaceuticals (NASDAQ: OLMA) led the way as the ...
Best Call Options to Trade Now for 300% Profit Potential
Today 12:00 EST
With all the enthusiasm over a new vaccine, money is flooding back into stocks, but investors and traders alike are leaving profits on the table if they aren't trading call options on the right stocks....
From Money Morning
Can Coronavirus Vaccine Stocks Keep Lifting the Stock Market?
Today 11:56 EST
Shares of air carriers were broadly higher Monday, following the busiest travel weekend in eight months and more good news on a potential COVID-19 vaccine.
Why Macy's Stock Is Soaring Today
Today 11:24 EST
AstraZeneca said its University of Oxford-partnered coronavirus vaccine was 70% effective, on average, in a key study — leading AZN stock to dive Monday. Some patients saw 90% effectiveness.
U.S. coronavirus case tally tops 12 million amid growing fears that Thanksgiving travel will spark another surge of infections
Today 10:59 EST
The global case tally for the coronavirus illness COVID-19 rose to 58.7 million on Monday and the U.S. tally rose above 12 million, with new daily infections heading toward 200,0000 a day amid growing...
Should Investors Consider These Coronavirus Stocks After AstraZeneca’s Vaccine News? 3 Names To Watch
Today 10:30 EST
Decision on approving Pfizer-BioNTech vaccine to be made in ‘shortest time possible,’ U.K. regulator says
Today 9:48 EST
The U.K. has ordered 40 million vaccine doses from Pfizer and BioNTech — enough for up to a third of the population.
AstraZeneca Coronavirus Vaccine Candidate Shows Up to 90% Efficacy in Interim Analysis
Today 9:46 EST
For the third time this month, a potential vaccine for the global scourge shows extremely strong results.
U.K.-based drugmaker AstraZeneca said on Monday that the coronavirus vaccine it is developing with the University of Oxford had shown an average efficacy of 70% in the Phase 3 trials.
3 Top Value Stocks To Buy Right Now
Today 9:21 EST
Energy: The End Of The Tunnel
Today 9:09 EST
Global supplies have tightened, and oil production has fallen, and more robust economic data and better than expected demand in Asia are starting to bolster prices.
U.S. government bonds see rates climb to start a holiday-shortened week, after the sharpest weekly yield drop for long-dated debt in months. Debt investors have been weighing the balance of risks of...
AstraZeneca COVID-19 Vaccine 70% Effective, UK Expects Millions Of Doses By Year's End
Today 8:37 EST
Continuing the pattern of leading COVID-19 vaccine projects releasing their Phase 3 trial results on Monday, AstraZeneca has revealed that its vaccine - is 70% effective at preventing the coronavirus.
Could Late-Stage Coronavirus Vaccine Trials Fail?
Today 8:33 EST
Dr. Jeremy Brown says that historically, 90% of vaccine trials fail. Does this data still hold or has the game changed?
Oil prices rise, remain buoyed by vaccine progress
Today 8:30 EST
Key Tips for Buying COVID Vaccine Stocks
Today 8:15 EST
Dow Jones Today Leads Futures Higher, Merck Jumps Into Covid Game; Regeneron Treatment Get FDA Nod
Today 8:12 EST
Regeneron and Gap were early leaders, Merck topped the Dow Jones today, as stock futures rose on coronavirus vaccine optimism.
U.K. stocks rose on Monday, after AstraZeneca reported its coronavirus vaccine was effective, giving a shot in the arm to travel, leisure and energy companies.